Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 72

1.

Serum growth factor stability in different eye drop packaging systems during storage.

Tan JCG, Webb RG, Marks DC.

Transfus Apher Sci. 2019 Jul 9. pii: S1473-0502(19)30139-9. doi: 10.1016/j.transci.2019.06.032. [Epub ahead of print]

PMID:
31320279
2.

A randomized, controlled pilot clinical trial of cryopreserved platelets for perioperative surgical bleeding: the CLIP-I trial.

Reade MC, Marks DC, Bellomo R, Deans R, Faulke DJ, Fraser JF, Gattas DJ, Holley AD, Irving DO, Johnson L, Pearse BL, Royse AG, Wong J; Cryopreserved vs Liquid Platelet (CLIP) Investigators, the Australian and New Zealand College of Anaesthetists Clinical Trials Network, and the Australian and New Zealand Intensive Care Society Clinical Trials Group.

Transfusion. 2019 Jul 10. doi: 10.1111/trf.15423. [Epub ahead of print]

PMID:
31290573
3.

The role of neuraminidase 1 and 2 in glycoprotein Ibα-mediated integrin αIIbβ3 activation.

van der Wal DE, Davis AM, Mach M, Marks DC.

Haematologica. 2019 Jul 4. pii: haematol.2019.215830. doi: 10.3324/haematol.2019.215830. [Epub ahead of print]

4.

Inactivation of yellow fever virus in plasma after treatment with methylene blue and visible light and in platelet concentrates following treatment with ultraviolet C light.

Faddy HM, Fryk JJ, Hall RA, Young PR, Reichenberg S, Tolksdorf F, Sumian C, Gravemann U, Seltsam A, Marks DC.

Transfusion. 2019 Jul;59(7):2223-2227. doi: 10.1111/trf.15332. Epub 2019 May 3.

PMID:
31050821
5.

Cryopreservation of UVC pathogen-inactivated platelets.

Waters L, Padula MP, Marks DC, Johnson L.

Transfusion. 2019 Jun;59(6):2093-2102. doi: 10.1111/trf.15204. Epub 2019 Feb 20.

PMID:
30790288
6.

The impact of refrigerated storage of UVC pathogen inactivated platelet concentrates on in vitro platelet quality parameters.

Johnson L, Cameron M, Waters L, Padula MP, Marks DC.

Vox Sang. 2019 Jan;114(1):47-56. doi: 10.1111/vox.12730. Epub 2018 Nov 30.

PMID:
30499111
7.

Comparison between manufacturing sites shows differential adhesion, activation, and GPIbα expression of cryopreserved platelets.

Six KR, Delabie W, Devreese KMJ, Johnson L, Marks DC, Dumont LJ, Compernolle V, Feys HB.

Transfusion. 2018 Nov;58(11):2645-2656. doi: 10.1111/trf.14828. Epub 2018 Oct 12.

PMID:
30312492
8.

Assays for phenotypic and functional characterization of cryopreserved platelets.

Marks DC, Johnson L.

Platelets. 2019;30(1):48-55. doi: 10.1080/09537104.2018.1514108. Epub 2018 Sep 25.

PMID:
30252562
9.

Cryopreserved platelets: are we there yet?

Marks DC.

Transfusion. 2018 Sep;58(9):2092-2094. doi: 10.1111/trf.14887. No abstract available.

PMID:
30204954
10.

Ultraviolet-Based Pathogen Inactivation Systems: Untangling the Molecular Targets Activated in Platelets.

Schubert P, Johnson L, Marks DC, Devine DV.

Front Med (Lausanne). 2018 May 7;5:129. doi: 10.3389/fmed.2018.00129. eCollection 2018. Review.

11.

Maximising platelet availability by delaying cold storage.

Wood B, Johnson L, Hyland RA, Marks DC.

Vox Sang. 2018 Apr 6. doi: 10.1111/vox.12649. [Epub ahead of print]

PMID:
29633290
12.

Refrigeration, cryopreservation and pathogen inactivation: an updated perspective on platelet storage conditions.

Waters L, Cameron M, Padula MP, Marks DC, Johnson L.

Vox Sang. 2018 May;113(4):317-328. doi: 10.1111/vox.12640. Epub 2018 Feb 14. Review.

PMID:
29441601
13.

Timing of gamma irradiation and blood donor sex influences in vitro characteristics of red blood cells.

de Korte D, Thibault L, Handke W, Harm SK, Morrison A, Fitzpatrick A, Marks DC, Yi QL, Acker JP; Biomedical Excellence for Safer Transfusion (BEST) collaborative.

Transfusion. 2018 Apr;58(4):917-926. doi: 10.1111/trf.14481. Epub 2018 Jan 17.

PMID:
29341199
14.

Characterization of biologic response modifiers in the supernatant of conventional, refrigerated, and cryopreserved platelets.

Johnson L, Tan S, Jenkins E, Wood B, Marks DC.

Transfusion. 2018 Apr;58(4):927-937. doi: 10.1111/trf.14475. Epub 2018 Jan 12.

PMID:
29330877
15.

International Forum on GMP-grade human platelet lysate for cell propagation: summary.

Strunk D, Lozano M, Marks DC, Loh YS, Gstraunthaler G, Schennach H, Rohde E, Laner-Plamberger S, Öller M, Nystedt J, Lotfi R, Rojewski M, Schrezenmeier H, Bieback K, Schäfer R, Bakchoul T, Waidmann M, Jonsdottir-Buch SM, Montazeri H, Sigurjonsson OE, Iudicone P, Fioravanti D, Pierelli L, Introna M, Capelli C, Falanga A, Takanashi M, Lόpez-Villar O, Burnouf T, Reems JA, Pierce J, Preslar AM, Schallmoser K.

Vox Sang. 2018 Jan;113(1):80-87. doi: 10.1111/vox.12593. Epub 2017 Oct 26. No abstract available.

PMID:
29076169
16.

International Forum on GMP-grade human platelet lysate for cell propagation.

Strunk D, Lozano M, Marks DC, Loh YS, Gstraunthaler G, Schennach H, Rohde E, Laner-Plamberger S, Öller M, Nystedt J, Lotfi R, Rojewski M, Schrezenmeier H, Bieback K, Schäfer R, Bakchoul T, Waidmann M, Jonsdottir-Buch SM, Montazeri H, Sigurjonsson OE, Iudicone P, Fioravanti D, Pierelli L, Introna M, Capelli C, Falanga A, Takanashi M, López-Villar O, Burnouf T, Reems JA, Pierce J, Preslar AM, Schallmoser K.

Vox Sang. 2018 Jan;113(1):e1-e25. doi: 10.1111/vox.12594. Epub 2017 Oct 25. No abstract available.

PMID:
29071726
17.

Vox Sanguinis International Forum on platelet cryopreservation: Summary.

Cohn CS, Dumont LJ, Lozano M, Marks DC, Johnson L, Ismay S, Bondar N, T'Sas F, Yokoyama APH, Kutner JM, Acker JP, Bohonek M, Sailliol A, Martinaud C, Pogłód R, Antoniewicz-Papis J, Lachert E, Pun PBL, Lu J, Cid J, Guijarro F, Puig L, Gerber B, Alberio L, Schanz U, Buser A, Noorman F, Zoodsma M, van der Meer PF, de Korte D, Wagner S, O'Neill M.

Vox Sang. 2017 Oct;112(7):684-688. doi: 10.1111/vox.12533. Epub 2017 Sep 20. No abstract available.

PMID:
28929502
18.

Vox Sanguinis International Forum on platelet cryopreservation.

Cohn CS, Dumont LJ, Lozano M, Marks DC, Johnson L, Ismay S, Bondar N, T'Sas F, Yokoyama APH, Kutner JM, Acker JP, Bohonek M, Sailliol A, Martinaud C, Pogłód R, Antoniewicz-Papis J, Lachert E, Pun PBL, Lu J, Cid J, Guijarro F, Puig L, Gerber B, Alberio L, Schanz U, Buser A, Noorman F, Zoodsma M, van der Meer PF, de Korte D, Wagner S, O'Neill M.

Vox Sang. 2017 Oct;112(7):e69-e85. doi: 10.1111/vox.12532. Epub 2017 Sep 20. No abstract available.

PMID:
28929500
19.

Immunomodulatory effect of cryopreserved platelets: altered BDCA3+ dendritic cell maturation and activation in vitro.

Ki KK, Johnson L, Faddy HM, Flower RL, Marks DC, Dean MM.

Transfusion. 2017 Dec;57(12):2878-2887. doi: 10.1111/trf.14320. Epub 2017 Sep 16.

PMID:
28921552
20.

Cryopreserved platelets demonstrate reduced activation responses and impaired signaling after agonist stimulation.

Waters L, Padula MP, Marks DC, Johnson L.

Transfusion. 2017 Dec;57(12):2845-2857. doi: 10.1111/trf.14310. Epub 2017 Sep 14.

PMID:
28905392
21.

Reduction of Zika virus infectivity in platelet concentrates after treatment with ultraviolet C light and in plasma after treatment with methylene blue and visible light.

Fryk JJ, Marks DC, Hobson-Peters J, Watterson D, Hall RA, Young PR, Reichenberg S, Tolksdorf F, Sumian C, Gravemann U, Seltsam A, Faddy HM.

Transfusion. 2017 Nov;57(11):2677-2682. doi: 10.1111/trf.14256. Epub 2017 Jul 17.

PMID:
28718518
22.

Postdonation iron replacement for maintaining iron stores in female whole blood donors in routine donor practice: results of two feasibility studies in Australia.

Pasricha SR, Marks DC, Salvin H, Brama T, Keller AJ, Pink J, Speedy J.

Transfusion. 2017 Aug;57(8):1922-1929. doi: 10.1111/trf.14173. Epub 2017 May 18.

PMID:
28518220
23.

Serum eye drops: a survey of international production methods.

Marks DC, van der Meer PF; Biomedical Excellence for Safer Transfusion (BEST) Collaborative.

Vox Sang. 2017 May;112(4):310-317. doi: 10.1111/vox.12502. Epub 2017 Mar 23.

PMID:
28332214
24.

Quality and Safety of Blood Products.

Ramirez-Arcos S, Marks DC, Acker JP, Sheffield WP.

J Blood Transfus. 2016;2016:2482157. doi: 10.1155/2016/2482157. Epub 2016 Dec 29. No abstract available.

25.

Quality Assessment of Established and Emerging Blood Components for Transfusion.

Acker JP, Marks DC, Sheffield WP.

J Blood Transfus. 2016;2016:4860284. doi: 10.1155/2016/4860284. Epub 2016 Dec 14. Review.

26.

Mitigating the Risk of Transfusion-Transmitted Dengue in Australia.

Rooks K, Seed CR, Fryk JJ, Hyland CA, Harley RJ, Holmberg JA, Marks DC, Flower RL, Faddy HM.

J Blood Transfus. 2016;2016:3059848. Epub 2016 Nov 13.

27.

Reduction of biological response modifiers in the supernatant of washed paediatric red blood cells.

Loh YS, Tan S, Kwok M, Stark MJ, Marks DC.

Vox Sang. 2016 Nov;111(4):365-373. doi: 10.1111/vox.12442. Epub 2016 Oct 19.

PMID:
27864978
28.

Riboflavin and ultraviolet light: impact on dengue virus infectivity.

Faddy HM, Fryk JJ, Watterson D, Young PR, Modhiran N, Muller DA, Keil SD, Goodrich RP, Marks DC.

Vox Sang. 2016 Oct;111(3):235-241. doi: 10.1111/vox.12414. Epub 2016 Jun 9.

PMID:
27281512
29.

Refrigerated storage of platelets initiates changes in platelet surface marker expression and localization of intracellular proteins.

Wood B, Padula MP, Marks DC, Johnson L.

Transfusion. 2016 Oct;56(10):2548-2559. doi: 10.1111/trf.13723. Epub 2016 Jul 26.

PMID:
27460096
30.

Dengue and chikungunya viruses in plasma are effectively inactivated after treatment with methylene blue and visible light.

Fryk JJ, Marks DC, Hobson-Peters J, Prow NA, Watterson D, Hall RA, Young PR, Reichenberg S, Sumian C, Faddy HM.

Transfusion. 2016 Sep;56(9):2278-85. doi: 10.1111/trf.13729. Epub 2016 Jul 25.

PMID:
27456861
31.

Perspectives on the use of biomaterials to store platelets for transfusion.

Farrugia BL, Chandrasekar K, Johnson L, Whitelock JM, Marks DC, Irving DO, Lord MS.

Biointerphases. 2016 Jun 27;11(2):029701. doi: 10.1116/1.4952450. Review.

PMID:
27233532
32.

Refrigeration and cryopreservation of platelets differentially affect platelet metabolism and function: a comparison with conventional platelet storage conditions.

Johnson L, Tan S, Wood B, Davis A, Marks DC.

Transfusion. 2016 Jul;56(7):1807-18. doi: 10.1111/trf.13630. Epub 2016 May 9.

PMID:
27158813
33.

Inactivation of dengue, chikungunya, and Ross River viruses in platelet concentrates after treatment with ultraviolet C light.

Faddy HM, Fryk JJ, Prow NA, Watterson D, Young PR, Hall RA, Tolksdorf F, Sumian C, Gravemann U, Seltsam A, Marks DC.

Transfusion. 2016 Jun;56(6 Pt 2):1548-55. doi: 10.1111/trf.13519. Epub 2016 Mar 1.

PMID:
26926832
34.

Quality standards, safety and efficacy of blood-derived serum eye drops: A review.

van der Meer PF, Seghatchian J, Marks DC.

Transfus Apher Sci. 2016 Feb;54(1):164-7. doi: 10.1016/j.transci.2016.01.022. Epub 2016 Jan 20. Review.

PMID:
26847866
35.

A patient focused application of a non-conventional blood components- autologous serum eye drops--and current opinions on substances used for clinical management of acute haemorrhage for shock/trauma.

Seghatchian J, Marks DC.

Transfus Apher Sci. 2015 Dec;53(3):403. doi: 10.1016/j.transci.2015.11.010. Epub 2015 Nov 26. No abstract available.

PMID:
26626965
36.

Platelet microparticles in cryopreserved platelets: Potential mediators of haemostasis.

Johnson L, Raynel S, Seghatchian J, Marks DC.

Transfus Apher Sci. 2015 Oct;53(2):146-52. doi: 10.1016/j.transci.2015.10.011. Epub 2015 Oct 27. Review.

PMID:
26549672
37.

The impact on blood donor screening for human immunodeficiency virus, hepatitis C virus, and hepatitis B virus using plasma from frozen-thawed plasma preparation tubes.

Allison KM, Faddy HM, Margaritis A, Ismay S, Marks DC.

Transfusion. 2016 Feb;56(2):449-56. doi: 10.1111/trf.13372. Epub 2015 Oct 12.

PMID:
26456378
38.

Extended storage and glucose exhaustion are associated with apoptotic changes in platelets stored in additive solution.

Johnson L, Schubert P, Tan S, Devine DV, Marks DC.

Transfusion. 2016 Feb;56(2):360-8. doi: 10.1111/trf.13345. Epub 2015 Oct 4.

PMID:
26434768
39.

Serum eye drop preparation in Australia: Current manufacturing practice.

Marks DC, Fisher J, Mondy P, Segatchian J, Dennington PM.

Transfus Apher Sci. 2015 Aug;53(1):92-4. doi: 10.1016/j.transci.2015.05.015. Epub 2015 Jun 9. Review.

PMID:
26123029
40.

Cryopreservation alters the membrane and cytoskeletal protein profile of platelet microparticles.

Raynel S, Padula MP, Marks DC, Johnson L.

Transfusion. 2015 Oct;55(10):2422-32. doi: 10.1111/trf.13165. Epub 2015 Jun 3.

PMID:
26046916
41.

Treatment of platelets with riboflavin and ultraviolet light mediates complement activation and suppresses monocyte interleukin-12 production in whole blood.

Loh YS, Dean MM, Johnson L, Marks DC.

Vox Sang. 2015 Nov;109(4):327-35. doi: 10.1111/vox.12283. Epub 2015 May 14.

PMID:
25975771
42.

Gamma-irradiation of deglycerolized red cells does not significantly affect in vitro quality.

Winter KM, Johnson L, Webb RG, Marks DC.

Vox Sang. 2015 Oct;109(3):231-8. doi: 10.1111/vox.12282. Epub 2015 May 7.

PMID:
25953334
43.

Propensity of red blood cells to undergo P2X7 receptor-mediated phosphatidylserine exposure does not alter during in vivo or ex vivo aging.

Sophocleous RA, Mullany PR, Winter KM, Marks DC, Sluyter R.

Transfusion. 2015 Aug;55(8):1946-54. doi: 10.1111/trf.13101. Epub 2015 Mar 30.

PMID:
25823581
44.

Preparation of red blood cell concentrates and plasma units from whole blood held overnight using a hollow-fibre separation system.

Johnson L, Kwok M, Marks DC.

Transfus Med. 2015 Feb;25(1):13-9. doi: 10.1111/tme.12192. Epub 2015 Mar 23.

PMID:
25808374
45.

In vitro comparison of cryopreserved and liquid platelets: potential clinical implications.

Johnson L, Reade MC, Hyland RA, Tan S, Marks DC.

Transfusion. 2015 Apr;55(4):838-47. doi: 10.1111/trf.12915. Epub 2014 Nov 5.

PMID:
25371169
46.

The effect of riboflavin and ultraviolet light on the infectivity of arboviruses.

Faddy HM, Prow NA, Fryk JJ, Hall RA, Keil SD, Goodrich RP, Marks DC.

Transfusion. 2015 Apr;55(4):824-31. doi: 10.1111/trf.12899. Epub 2014 Nov 5.

PMID:
25370822
47.

Understanding the effects of gamma-irradiation on potassium levels in red cell concentrates stored in SAG-M for neonatal red cell transfusion.

Winter KM, Johnson L, Kwok M, Reid S, Alarimi Z, Wong JK, Dennington PM, Marks DC.

Vox Sang. 2015 Feb;108(2):141-50. doi: 10.1111/vox.12194. Epub 2014 Sep 8.

PMID:
25195496
48.

Iron deficiency in blood donors: a national cross-sectional study.

Salvin HE, Pasricha SR, Marks DC, Speedy J.

Transfusion. 2014 Oct;54(10):2434-44. doi: 10.1111/trf.12647. Epub 2014 Apr 17.

PMID:
24738792
49.

An 8-week course of 45 mg of carbonyl iron daily reduces iron deficiency in female whole blood donors aged 18 to 45 years: results of a prospective randomized controlled trial.

Marks DC, Speedy J, Robinson KL, Brama T, Capper HR, Mondy P, Keller AJ.

Transfusion. 2014 Mar;54(3 Pt 2):780-8. doi: 10.1111/trf.12464. Epub 2013 Oct 28.

PMID:
24660763
50.

Red blood cell in vitro quality and function is maintained after S-303 pathogen inactivation treatment.

Winter KM, Johnson L, Kwok M, Vidovic D, Hyland RA, Mufti N, Erickson A, Marks DC.

Transfusion. 2014 Jul;54(7):1798-807. doi: 10.1111/trf.12545. Epub 2014 Mar 11.

PMID:
24617658

Supplemental Content

Loading ...
Support Center